Rate control and sinus rhythm maintenance in atrial fibrillation: National trends in medication use, 1980-1996

Archives of Internal Medicine

Volumn 158, Issue 19, 1998, Pages 2144-2148

  Stafford, Randall S ^a   Robson, Deborah C ^a   Misra, Bismruta ^a   Ruskin, Jeremy ^a   Singer, Daniel E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE PHOSPHATE; ENCAINIDE; FLECAINIDE ACETATE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ARTICLE; DRUG USE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINUS RHYTHM; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DIGOXIN; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; HEART RATE; HUMANS; LINEAR MODELS; OFFICE VISITS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0032569643     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.19.2144     Document Type: Article

References (34)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med. 1987;147:1561-1564.
2. Aboaf AP, Wolf PS. Paroxysmal atrial fibrillation: a common but neglected entity. Arch Intern Mett. 1996;156:362-367.
3. Gilligan DM, Ellenbogen KA, Epstein AE. The management of atrial fibrillation. Am J Med. 1996;101:413-421.
4. Nattel S. Newer developments in the management of atrial fibrillation. Am Heart J. 1995;130:1094-1106.
5. Pritchett ELC. Management of atrial fibrillation. N Engl J Med. 1992;326:1264-1271.
6. The Planning and Steering Committees of the AFFIRM Study for the National Heart, Lung, and Blood Institute AFFIRM Investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management: the AFFIRM study design. Am J Cardiol. 1997; 79:1198-1202.
7. National Center for Health Statistics. Public Use Data Tape Documentation: 1980 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1982.
8. National Center for Health Statistics. Public Use Data Tape Documentation: 1981 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1984.
9. National Center for Health Statistics. Public Use Data Tape Documentation: 1985 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1987.
10. National Center for Health Statistics. Public Use Data Tape Documentation: 1989 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1992.
11. National Center for Health Statistics. Public Use Data Tape Documentation: 1990 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Hearth Statistics, US Public Health Service; 1992.
12. National Center for Health Statistics. Public Use Data Tape Documentation: 1991 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1993.
13. National Center for Health Statistics. Public Use Data Tape Documentation: 1992 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1994.
14. National Center for Health Statistics. Public Use Data Tape Documentation: 1993 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1995.
15. National Center for Health Statistics. Public Use Data Tape Documentation: 1994 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1996.
16. National Center for Health Statistics. Public Use Data Tape Documentation: 1995 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Hearth Service; 1997.
17. National Center for Health Statistics. Public Use Data Tape Documentation: 1996 National Ambulatory Medical Care Survey. Hyattsville, Md: National Center for Health Statistics, US Public Health Service; 1998.
18. Potthoff RF, Woodbury MA, Manton KG. "Equivalent sample size" and "equivalent degrees of freedom" refinements for inference using survey weights under superpopulation models. J Am Stat Assoc. 1992;87:383-396.
19. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
20. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC: SAS Inc; 1990.
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
22. CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
23. Echt DS, Liebson PR, Mitchell B, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med. 1991;324:781-788.
24. Ruskin J. The Cardiac Arrhythmia Suppression Trial (CAST). N Engl J Med. 1989; 321:386-388.
25. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Anti-arrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol. 1992;20:527-532.
26. Coplen SE, Antman EM, Berlin JA. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation. 1990;82:1106-1116.
27. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med. 1991;114:573-575.
28. Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation: a statement for healthcare professionals: from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996;93:1262-1277.
29. Disch DL, Greenberg ML, Holzberger PT, Malenka DJ, Birkmeyer D. Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med. 1994;120:449-457.
30. Greenberg ML, Malenka DJ, Disch DL. Therapeutic strategies for artial fibrillation: the value of decision analysis. Cardiol Clin. 1996;14:623-640.
31. Lazzari JO, Gonzales J. Reversible high rate atrial fibrillation dilated cardiomyopathy. Heart. 1997;77:486.
32. Col F, McLaughlin TJ, Soumerai SB, et al. The impact of clinical trials on the use of medications for acute myocardial infarction. Arch Intern Med. 1996;156:54-60.
33. Stafford RS, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med. 1996;156:2537-2541.
34. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med. 1995;333:565-572.